Side Letter: CalSTRS bags 52%; PE competes on comp; SEC alum talks GP-led reg risks

CalSTRS has reported an eye-watering PE return as it pivots towards co-investing. Plus: What PE's biggest firms are paying their junior staff and regulatory risks to be aware of when conducting a GP-focused secondaries deal. Here's today's brief, for our valued subscribers only.